These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 21074860)

  • 21. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication.
    Sibitz I; Katschnig H; Goessler R; Unger A; Amering M
    Pharmacopsychiatry; 2005 May; 38(3):107-12. PubMed ID: 15902579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
    de Haan L; van Amelsvoort T; Dingemans P; Linszen D
    Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
    Misdrahi D; Verdoux H; Lançon C; Bayle F
    Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
    Tsang HW; Fung KM; Corrigan PW
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
    Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
    J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of symptom resolution on medication adherence in first episode psychosis.
    Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
    Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
    Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
    Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
    Murawiec S
    Psychiatr Pol; 2005; 39(6):1185-98. PubMed ID: 16526184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.